Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Metabolomics of Anaphylaxis

NCT01666275 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT01666275
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01666275 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Metabolomics of Anaphylaxis
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Withdrawn
Start date
March 31, 2012
Completion date
August 14, 2018
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients with aerd undergoing aspirin desensitization